Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

KalVista Pharmaceuticals (KALV) Interest Expenses (2016)

Historic Interest Expenses for KalVista Pharmaceuticals (KALV) over the last 3 years, with Q1 2016 value amounting to $88000.0.

  • KalVista Pharmaceuticals' Interest Expenses fell 8947.37% to $88000.0 in Q1 2016 from the same period last year, while for Jan 2017 it was $88000.0, marking a year-over-year change of. This contributed to the annual value of $5.8 million for FY2025, which is N/A changed from last year.
  • Per KalVista Pharmaceuticals' latest filing, its Interest Expenses stood at $88000.0 for Q1 2016, which was down 8947.37% from $88000.0 recorded in Q4 2015.
  • KalVista Pharmaceuticals' Interest Expenses' 5-year high stood at $836000.0 during Q1 2015, with a 5-year trough of $80000.0 in Q1 2014.
  • In the last 3 years, KalVista Pharmaceuticals' Interest Expenses had a median value of $95000.0 in 2015 and averaged $262000.0.
  • Its Interest Expenses has fluctuated over the past 5 years, first skyrocketed by 94500.0% in 2015, then plummeted by 8947.37% in 2016.
  • Quarter analysis of 3 years shows KalVista Pharmaceuticals' Interest Expenses stood at $562000.0 in 2014, then tumbled by 84.34% to $88000.0 in 2015, then changed by 0.0% to $88000.0 in 2016.
  • Its Interest Expenses stands at $88000.0 for Q1 2016, versus $88000.0 for Q4 2015 and $95000.0 for Q3 2015.